NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in COVID-19 patients Read more
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms Read more
Skin cells from frontotemporal dementia patients may prove useful in revealing disease mechanisms and in biomarker and drug research Read more
Heat-tolerant COVID-19 vaccine from IISc effective against all major SARS-CoV-2 variants: Study Read more
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of linezolid Read more